Dexmedetomidine reduces sevoflurane EC50 for supraglottic airway device insertion in spontaneously breathing morbidly obese patients

Dexmedetomidine reduces sevoflurane EC50 for supraglottic airway device insertion in spontaneously breathing morbidly obese patients

Lei Wan,1 Liu-Jia-Zi Shao,1 Yang Liu,2 Hai-Xia Wang,1 Fu-Shan Xue,1 Ming Tian11Department of Anesthesiology, Beijing Friendship Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Department of General Surgery, Beijing Friendship Hospital, Capital Medical University...

Full description

Bibliographic Details
Main Authors: Wan L, Shao LJZ, Liu Y, Wang HX, Xue FS, Tian M
Format: Article
Language:English
Published: Dove Medical Press 2019-05-01
Series:Therapeutics and Clinical Risk Management
Subjects:
Obesity
Inhalational induction
Sevoflurane
Dexmedetomidine
Supraglottic airway device.
Online Access:https://www.dovepress.com/dexmedetomidine-reduces-sevoflurane-ec50-for-supraglottic-airway-devic-peer-reviewed-article-TCRM

Internet

https://www.dovepress.com/dexmedetomidine-reduces-sevoflurane-ec50-for-supraglottic-airway-devic-peer-reviewed-article-TCRM

Similar Items